A new score for detection of early cardioversion using intravenous amiodarone in recent onset atrial fibrillation

Background: Amiodarone is the only available intravenous antiarrhythmic medication in Egypt used in acute AF cardioversion. Cardioversion using IV amiodarone takes 6–8 h, and can be as late as 16 h. The aim of this study was to identify the clinical factors that are most associated with early (<8...

Full description

Bibliographic Details
Published in:	The Egyptian Heart Journal
Main Authors:	Hisham Samir Roshdy, Tarek Ahmed Naguib, Mohamed Abdalla Elthalawi
Format:	Article
Language:	English
Published:	SpringerOpen 2016-12-01
Subjects:	Acute atrial fibrillation Antiarrhythmic medication Electrical cardioversion
Online Access:	http://www.sciencedirect.com/science/article/pii/S1110260816300047

Similar Items

Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation
by: Marco Valerio Mariani, et al.
Published: (2022-10-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

Efficiency and safety of pharmacological cardioversion for atrial fibrillation
by: Aleksei V. Tarasov
Published: (2021-04-01)

Pharmacological cardioversion of atrial fibrillation paroxysm in elderly and senile patients at prehospital stage
by: Andrei V. Syrov
Published: (2021-03-01)

Serial electrical cardioversion for refractory atrial fibrillation with rapid ventricular response post ablation
by: Katherine Liu, et al.
Published: (2025-10-01)

Analysis of drug-induced and spontaneous cardioversions reveals similar patterns leading to termination of atrial fibrillation
by: Arne van Hunnik, et al.
Published: (2024-07-01)

Effectiveness of сavutilide in restoring sinus rhythm in patients with atrial fibrillation and flutter following prior unsuccessful electrical cardioversion
by: Kh. M. Dzaurova, et al.
Published: (2025-06-01)

Preliminary results of a prospective randomized study comparing the efficacy and safety of refralon and amiodarone in cardioversion in patients with paroxysmal atrial fibrillation and flutter
by: D. A. Gagloeva, et al.
Published: (2023-05-01)

Current Status of Internal Cardioversion in Atrial Fibrillation.
by: Andreas Plewan, et al.
Published: (2002-04-01)

Guidelines for the clinical management of atrial fibrillation: a practical perspective
by: E Blanc, et al.
Published: (2004-05-01)

Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure
by: Maria M. Beliaeva, et al.
Published: (2023-12-01)

Paroxysmal atrial fibrillation: treatment choice
by: B. A. Tatarsky
Published: (2007-06-01)

Predictors of time to conversion of new‐onset atrial fibrillation to sinus rhythm with amiodarone therapy
by: Ihsan Dursun, et al.
Published: (2020-08-01)

THE IMPORTANCE OF EARLY CARDIOVERSION OF PAROXYSMAL ATRIAL FIBRILLATION
by: Franc Verovnik
Published: (2002-01-01)

Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation – the FinCV-4 study
by: Samuli Jaakkola, et al.
Published: (2022-12-01)

Cardioversion of atrial fibrillation does not affect obstructive sleep apnea
by: Niklas Höglund, et al.
Published: (2017-04-01)

Rivaroxaban in atrial fibrillation cardioversion: an update
by: Lavalle C, et al.
Published: (2019-05-01)

Usefulness of risk scores and predictors of atrial fibrillation recurrence after elective electrical cardioversion
by: Daniel Águila‐Gordo, et al.
Published: (2024-01-01)

The efficacy of synchronized direct current shock in reverting long standing persistent atrial fibrillation in to sinus rhythm. What help to achieve high success rate?
by: AMAR Talib AL-HAMDI, et al.
Published: (2021-05-01)

Prevalence and risk factors associated with decompensated heart failure after successful elective cardioversion for atrial fibrillation and atrial flutter
by: Christina Healy, et al.
Published: (2024-11-01)

Comparison of efficacy of pharmacological cardioversion with antazoline and propafenone versus electrical cardioversion in atrial fibrillation during cryoablation
by: Konrad Klocek, et al.
Published: (2024-03-01)

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
by: N. A. Novikova, et al.
Published: (2016-11-01)

Investigation of predictive parameters for recurrence in patients undergoing electrical cardioversion for atrial fibrillation
by: Levent Pay, et al.
Published: (2025-04-01)

MR-proANP, sST2, BNP and sinus rhythm maintenance 1 year after electrical cardioversion for atrial fibrillation
by: Marc Badoz, et al.
Published: (2025-08-01)

Early Risk of Stroke in Patients Undergoing Acute Versus Elective Cardioversion for Atrial Fibrillation
by: Tomas Forslund, et al.
Published: (2021-08-01)

The Role of Biphasic Shocks for Transthoracic Cardioversion of Atrial Fibrillation
by: Simon J Walsh, et al.
Published: (2005-10-01)

Value of transoesophageal echocardiography-guided approach to electrical cardioversion of atrial fibrillation
by: O. S. Kalashnikovа
Published: (2013-06-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety
by: N. Yu. Mironov, et al.
Published: (2019-01-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation
by: I. G. Fomina, et al.
Published: (2005-08-01)

Obese patients with new onset atrial fibrillation/flutter have higher risk of hospitalization, cardioversions, and ablations
by: Jonathan Norton, et al.
Published: (2024-04-01)

The clinical condition and functional performance of the heart in patients with persistent atrial fibrillation after electrical cardioversion.
by: K. А. Pysarevska
Published: (2016-03-01)

The clinical condition and functional performance of the heart in patients with persistent atrial fibrillation after electrical cardioversion
by: Pysarevska K.О.
Published: (2016-03-01)

Predictors of long-term outcomes in patients with persistent atrial fibrillation undergoing electrical cardioversion
by: Mohammad Reza Dehghani, et al.
Published: (2024-03-01)

What Governs Immediate or Delayed Cardioversion of Atrial Fibrillation by Direct Current Shock?
by: Amar T. AL-Hamdi, et al.
Published: (2024-12-01)

Ventricular arrhythmias after atrial fibrillation electrical cardioversion: A multicenter study
by: Oholi Tovia-Brodie, MD, et al.
Published: (2024-11-01)

Insights from clinical trials: New evidence supports surgical interventions over drug therapies for atrial fibrillation
by: Akshat D. Modi, et al.
Published: (2024-06-01)

Body surface mapping of P-waves in sinus rhythm to predict recurrence following cardioversion for atrial fibrillation
by: Ibrahim Antoun, et al.
Published: (2024-07-01)

Frequency Analysis of Atrial Fibrillation From the Surface Electrocardiogram
by: Daniela Husser, et al.
Published: (2004-07-01)

Atrial fibrillation: real-life experience of a rhythm control with electrical cardioversion in a community hospital
by: Artemiy Okhotin, et al.
Published: (2024-04-01)

Automatically optimized vectorcardiographic features are associated with recurrence of atrial fibrillation after electrical cardioversion
by: F. Plesinger, et al.
Published: (2025-01-01)